KEY TAKEAWAYS The study aimed to investigate the efficacy and safety of TAS-102 in patients with fluoropyrimidine-refractory PC. The primary endpoint was to determine the PFS rate. Researchers noticed the promising efficacy and acceptable safety of TAS-102; further...